Table 1: Malignant tumors of the nasal cavity: Endonasal approach with endoscopes.
Age | Sex | Signs/symptoms | Location | Histology | Adjuvant/neoadjuvant treatment | Local control | Follow-up |
53 | M | Epistaxis | Anterior nasal septum | Angiosarcoma | Not | No tumor | 23 years |
72 | M | Epistaxis | Middle nasal septum | Low grade adenocarcinoma | Not | No tumor | 20 years |
62 | M | Epistaxis | Posterior nasal septum | Metastasis of renal clear cell adenocarcinoma | Not | No tumor | 4 years |
26 | M | Epistaxis | Anterior nasal septum | Angiosarcoma | Not | No tumor | 6 years |
62 | M | Epistaxis | Lower turbinate | Metastasis of renal clear cell adenocarcinoma | Not | No tumor | 1 year |
70 | M | Nasal obstruction | Nasal cavity floor | Melanoma T3 | Not | No tumor | 1 year |
70 | M | Nasal obstruction | Anterior nasal septum | Squamous cell carcinoma T1 | Not | No tumor | 9 years |
73 | M | Epistaxis/nasal obstruction | Lower turbinate | Melanoma T3 | Not | No tumor | 8 years |
32 | M | Nasal obstruction | Anterior nasal septum | Squamous cell carcinoma T1 | Not | No tumor | 7 years |
55 | M | Nasal obstruction | Lower turbinate | Adenocarcinoma | Not | No tumor | 1 year |